open access

Vol 58, No 1 (2007)
Original papers
Published online: 2007-01-31
Submitted: 2013-02-15
Get Citation

The treatment of multinodular large non-toxic goiter using repeated doses of radioiodine (preliminary report)

Marlena Pisarek, Maciej Bączyk, Maria Gryczyńska, Jerzy Sowiński
Endokrynologia Polska 2007;58(1):18-26.

open access

Vol 58, No 1 (2007)
Original papers
Published online: 2007-01-31
Submitted: 2013-02-15

Abstract


Introduction: The aim of study was to establish the effectiveness of radioiodine therapy using 131-I in the group of patients with multinodular large non-toxic goiter.
Material and methods: Therapy was undertaken in female patients disqualified from surgery due to high risk and these patients who didn’t agree to surgery. Studies were performed in 7 women (age range: 62-82 yrs) with large goiters (2nd degree according to WHO classification and goiter volume assessed by USG over 100 cm3). Serum TSH, fT4, fT3, antithyroid antibodies (TPOAb, TgAb, TRAb) levels, urinary iodine concentration (UIE) were estimated in all patients parallel with radioiodine uptake test (after 5 and 24 hours), 131-I thyroid scintigraphy and fine needle biopsy to exclude neoplasmatic transformation. These studies and therapy with 22 mCi 131-I were repeated every 3 months.
Results: Before therapy median thyroid volume was approximately 145 cm3 and during therapy gradually decreased to 76 cm3 after 6 months and to 65 cm3 after 12 months. Increase of TRAb can be a inhibiting factor of thyroid volume reduction. Other antithyroid antibodies showed marked tendency to rise but without significant correlation with radioiodine uptake and goiter reduction. After 12 months we found 2 patients with clinical and laboratory hypothyroidism.
Conclusions: In some cases of multinodular large non-toxic goiter, the radioiodine therapy can be the best alternative way for L-thyroxine treatment or surgery therapy. The fractionated radioiodine therapy of multinodular large non-toxic goiter is safe and effective method but continuation of nodules observation is necessary.

Abstract


Introduction: The aim of study was to establish the effectiveness of radioiodine therapy using 131-I in the group of patients with multinodular large non-toxic goiter.
Material and methods: Therapy was undertaken in female patients disqualified from surgery due to high risk and these patients who didn’t agree to surgery. Studies were performed in 7 women (age range: 62-82 yrs) with large goiters (2nd degree according to WHO classification and goiter volume assessed by USG over 100 cm3). Serum TSH, fT4, fT3, antithyroid antibodies (TPOAb, TgAb, TRAb) levels, urinary iodine concentration (UIE) were estimated in all patients parallel with radioiodine uptake test (after 5 and 24 hours), 131-I thyroid scintigraphy and fine needle biopsy to exclude neoplasmatic transformation. These studies and therapy with 22 mCi 131-I were repeated every 3 months.
Results: Before therapy median thyroid volume was approximately 145 cm3 and during therapy gradually decreased to 76 cm3 after 6 months and to 65 cm3 after 12 months. Increase of TRAb can be a inhibiting factor of thyroid volume reduction. Other antithyroid antibodies showed marked tendency to rise but without significant correlation with radioiodine uptake and goiter reduction. After 12 months we found 2 patients with clinical and laboratory hypothyroidism.
Conclusions: In some cases of multinodular large non-toxic goiter, the radioiodine therapy can be the best alternative way for L-thyroxine treatment or surgery therapy. The fractionated radioiodine therapy of multinodular large non-toxic goiter is safe and effective method but continuation of nodules observation is necessary.
Get Citation

Keywords

large goiter; radioiodine therapy; radioiodine uptake; antithyroid antibodies

About this article
Title

The treatment of multinodular large non-toxic goiter using repeated doses of radioiodine (preliminary report)

Journal

Endokrynologia Polska

Issue

Vol 58, No 1 (2007)

Pages

18-26

Published online

2007-01-31

Bibliographic record

Endokrynologia Polska 2007;58(1):18-26.

Keywords

large goiter
radioiodine therapy
radioiodine uptake
antithyroid antibodies

Authors

Marlena Pisarek
Maciej Bączyk
Maria Gryczyńska
Jerzy Sowiński

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl